Letter: Vitamin D Deficiency and Autoimmune Hepatitis - From Research to Treatment-Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Vitamin D Deficiency and Autoimmune Hepatitis - From Research to Treatment

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Severe Vitamin D Deficiency Is a Prognostic Biomarker in Autoimmune Hepatitis-Offender or Bystander? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Severe Vitamin D Deficiency Is a Prognostic Biomarker in Autoimmune Hepatitis-Offender or Bystander?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Authors Reply Letter to the Reviewers

2020English

Editorial: The Role of Vitamin D in Autoimmune Hepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Authors’ Reply to the Letter to the Editor From Mukhdomi and Kendall

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy